EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY-NC 4.0

Mapping MMI Pharmindex Items to RxNorm Semantic Clinical Drugs – An Evaluation Study

Markus Budeus, Lucy Strüfing, Editha Räuscher, Martin Boeker

Studies in Health Technology and Informatics · 2026

DOI: 10.3233/shti260979 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Studies in Health Technology and Informatics, 2026. Verfasst von Markus Budeus und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Medical Informatics, Institute for AI and Informatics in Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich, Munich, Ger…. Hauptthemen laut MEDLINE: RxNorm, Semantics, Vocabulary, Controlled. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Terminologies are essential for the interoperability of healthcare data and enabling high-quality medical research. The Medical Informatics Initiative Germany currently relies on data from the MMI Pharmindex to identify medications; however, this database lacks international drug-level terminology. Therefore, this study aims to develop an algorithm to map RxNorm Semantic Clinical Drugs (SCDs) to medications in the MMI Pharmindex and to validate the accuracy of these mappings.

Methods

Using existing RxNorm identifiers at the substance level, we identified candidate RxNorm SCDs by using relationships within the RxNorm dataset. Candidates were retained if they matched MMI Pharmindex entries with respect to ingredients, strengths, and dose form. The resulting mappings were evaluated using a combination of automatic and manual validation procedures.

Results

At least one matching RxNorm SCD was identified for 18,326 medications. Among the evaluated mappings, different validation approaches indicated an approximate precision of 90%. The remaining discrepancies were predominantly attributable to ambiguous or suboptimal matches rather than to clearly incorrect mappings. The observed recall was 15% when considering the full medication set, including medications for which no SCD exists and which therefore cannot be mapped.

Conclusion

We developed and validated an approach for mapping MMI Pharmindex medications to RxNorm SCDs, demonstrating high mapping precision where matches are available. While overall recall is limited by incomplete RxNorm concept coverage, the analysis highlights specific gaps and provides a structured basis for improving medication representation within the Medical Informatics Initiative Germany.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RxNormSemanticsVocabulary, ControlledGermanyAlgorithmsHumansTerminology as Topic

Stichwörter der Autor:innen

InteroperabilityMMI PharmindexMedical Informatics Initiative GermanyMedicationRxNorm

Autor:innen und Institutionen

  • Chair of Medical Informatics, Institute for AI and Informatics in Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Technical University of Munich, Munich, Germany.
  • TMF e.V., Berlin, Germany.

Zitieren

APA

Budeus, M., Strüfing, L., Räuscher, E., & Boeker, M. (2026). Mapping MMI Pharmindex Items to RxNorm Semantic Clinical Drugs – An Evaluation Study. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti260979

Vancouver

Budeus M, Strüfing L, Räuscher E, Boeker M. Mapping MMI Pharmindex Items to RxNorm Semantic Clinical Drugs – An Evaluation Study. Studies in Health Technology and Informatics. 2026. doi:10.3233/shti260979

BibTeX
@article{Budeus2026,
  author = {Budeus, Markus and Strüfing, Lucy and Räuscher, Editha and Boeker, Martin},
  title = {Mapping MMI Pharmindex Items to RxNorm Semantic Clinical Drugs – An Evaluation Study},
  journal = {Studies in Health Technology and Informatics},
  year = {2026},
  doi = {10.3233/shti260979}
}
Kostenlos starten →